Aurinia Pharmaceuticals Inc.·4

Feb 23, 4:04 PM ET

Robertson Stephen P. 4

4 · Aurinia Pharmaceuticals Inc. · Filed Feb 23, 2026

Research Summary

AI-generated summary of this filing

Updated

Aurinia (AUPH) EVP Stephen Robertson Surrenders 34,638 Shares for Taxes

What Happened
Stephen P. Robertson, Executive Vice President and General Counsel of Aurinia Pharmaceuticals (AUPH), had 34,638 shares withheld to satisfy tax withholding obligations related to the vesting of restricted stock units. The transaction is reported as a disposition (code F) at $14.40 per share, representing approximately $498,787 in value on February 20, 2026. This was a tax-withholding event tied to RSU vesting, not an open-market sale or a purchase.

Key Details

  • Transaction date and price: Feb 20, 2026 — 34,638 shares withheld at $14.40/share.
  • Total value of shares withheld: about $498,787.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Footnote: F1 — shares were withheld to satisfy tax withholding obligations upon RSU vesting.
  • Filing timeliness: Report filed Feb 23, 2026 for a Feb 20, 2026 transaction — appears timely (not marked late).

Context
Withholding shares to cover taxes on vested RSUs is a routine administrative action and does not necessarily indicate insider sentiment about the company. Dispositions under code F simply reflect tax payment via share surrender rather than a voluntary cash sale.

Insider Transaction Report

Form 4
Period: 2026-02-20
Robertson Stephen P.
EVP, General Counsel
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-02-20$14.40/sh34,638$498,787483,296 total
Footnotes (1)
  • [F1]Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units.
Signature
/s/ Stephen P. Robertson|2026-02-23

Documents

1 file
  • 4
    wk-form4_1771880670.xmlPrimary

    FORM 4